Woodline Partners’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-119,854
| Closed | -$1.22M | – | 840 |
|
|
2022
Q3 | $1.22M | Sell |
119,854
-2,123,619
| -95% | -$21.5M | 0.02% | 520 |
|
|
2022
Q2 | $20.3M | Buy |
2,243,473
+916,820
| +69% | +$8.31M | 0.31% | 96 |
|
|
2022
Q1 | $12.7M | Buy |
1,326,653
+751,540
| +131% | +$7.18M | 0.21% | 150 |
|
|
2021
Q4 | $6.36M | Sell |
575,113
-1,404,017
| -71% | -$15.5M | 0.09% | 255 |
|
|
2021
Q3 | $14.6M | Buy |
1,979,130
+1,604,218
| +428% | +$11.9M | 0.24% | 115 |
|
|
2021
Q2 | $5.44M | Buy |
+374,912
| New | +$5.44M | 0.1% | 209 |
|